SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-20-311899
Filing Date
2020-12-07
Accepted
2020-12-07 17:22:29
Documents
6

Document Format Files

Seq Description Document Type Size
1 424B5 d69540d424b5.htm 424B5 432359
2 GRAPHIC g69540dsp077.jpg GRAPHIC 61178
3 GRAPHIC g69540g1207223356647.jpg GRAPHIC 3526
4 GRAPHIC g69540g1207223357583.jpg GRAPHIC 3944
5 GRAPHIC g69540g30h52.jpg GRAPHIC 39235
6 GRAPHIC g69540g61d79.jpg GRAPHIC 100487
  Complete submission text file 0001193125-20-311899.txt   720846
Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-233564 | Film No.: 201373543
SIC: 2834 Pharmaceutical Preparations